Literature DB >> 5428619

Transplantation of primary explants of human tumour to mice treated with antilymphocyte serum.

B Phillips, J C Gazet.   

Abstract

Biopsies from 40 human tumours, obtained at operation, have been transplanted to mice treated with antilymphocyte serum (ALS); viable grafts were obtained from 6 tumours. A further 26 human tumours were transplanted to mice thymectomized as adults and treated with ALS; viable grafts were obtained in 6 cases.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5428619      PMCID： PMC2008510          DOI： 10.1038/bjc.1970.12

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  3 in total

1.  THYMECTOMY IN NEWBORN AND ADULT MICE.

Authors:  K SJODIN; A P DALMASSO; J M SMITH; C MARTINEZ
Journal:  Transplantation       Date:  1963-10       Impact factor: 4.939

2.  Subcutaneous growth of normal and malignant human tissues in heterologous hosts.

Authors:  H W TOOLAN
Journal:  Trans N Y Acad Sci       Date:  1955-06

3.  Effect of antilymphocyte serum on the growth of Hep 2 and HeLa cells in mice.

Authors:  B Phillips; J C Gazet
Journal:  Nature       Date:  1968-12-14       Impact factor: 49.962
  3 in total
  9 in total

1.  Antilymphocytic serum and tumour transplantation in the brain.

Authors:  A Ridley
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

2.  The growth kinetics of xenografts of human colorectal tumours in immune deprived mice.

Authors:  R G Pickard; L M Cobb; G G Steel
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

3.  Chemosensitivity studies on human tumour cells from a pancreatic carcinoma xenograft.

Authors:  I E Smith
Journal:  J R Soc Med       Date:  1979-04       Impact factor: 18.000

Review 4.  Xenograft and organoid model systems in cancer research.

Authors:  Margit Bleijs; Marc van de Wetering; Hans Clevers; Jarno Drost
Journal:  EMBO J       Date:  2019-07-08       Impact factor: 11.598

5.  Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.

Authors:  Wei Xu; Zheng-Yun Zhao; Qi-Ming An; Bin Dong; Ang Lv; Cheng-Peng Li; Xiao-Ya Guan; Xiu-Yun Tian; Jian-Hui Wu; Chun-Yi Hao
Journal:  Int J Med Sci       Date:  2020-10-22       Impact factor: 3.738

6.  Human myeloma marrow cells in immunologically deficient mice.

Authors:  D N Mitchell; R J Rees; A J Salsbury
Journal:  Br J Cancer       Date:  1974-07       Impact factor: 7.640

7.  The growth of human tumours in immunosuppressed mice and their response to chemotherapy.

Authors:  M C Berenbaum; C E Sheard; J R Reittie; R V Bundick
Journal:  Br J Cancer       Date:  1974-07       Impact factor: 7.640

8.  Transplantation of human tumour to immune deprived mice treated with anti-thymocyte serum.

Authors:  S I Detre; J C Gazet
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640

9.  Metastatic spread of human tumour implanted into thymectomized, antithymocyte serum treated hamsters.

Authors:  L M Cobb
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.